APA (7th ed.) Citation

Liang, X., Li, Y., Wu, Y., Wu, T., Huang, D., Tang, Z., . . . Liu, Y. (2025). Human umbilical cord mesenchymal stem cell-derived microvesicles alleviate pulmonary fibrosis by inhibiting monocyte‒macrophage migration through ERK1/2 signaling-mediated suppression of CCL2 expression. Stem Cell Research & Therapy, 16(1), 1. https://doi.org/10.1186/s13287-025-04266-w

Chicago Style (17th ed.) Citation

Liang, Xiuping, et al. "Human Umbilical Cord Mesenchymal Stem Cell-derived Microvesicles Alleviate Pulmonary Fibrosis by Inhibiting Monocyte‒macrophage Migration Through ERK1/2 Signaling-mediated Suppression of CCL2 Expression." Stem Cell Research & Therapy 16, no. 1 (2025): 1. https://doi.org/10.1186/s13287-025-04266-w.

MLA (9th ed.) Citation

Liang, Xiuping, et al. "Human Umbilical Cord Mesenchymal Stem Cell-derived Microvesicles Alleviate Pulmonary Fibrosis by Inhibiting Monocyte‒macrophage Migration Through ERK1/2 Signaling-mediated Suppression of CCL2 Expression." Stem Cell Research & Therapy, vol. 16, no. 1, 2025, p. 1, https://doi.org/10.1186/s13287-025-04266-w.